Business Description
Mangalam Drugs & Organics Ltd
ISIN : INE584F01014
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.2 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.56 | |||||
Debt-to-EBITDA | 2.57 | |||||
Interest Coverage | 1.66 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.65 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.3 | |||||
3-Year EBITDA Growth Rate | -36.7 | |||||
3-Year FCF Growth Rate | -26.8 | |||||
3-Year Book Growth Rate | 1.3 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.61 | |||||
9-Day RSI | 35.35 | |||||
14-Day RSI | 41.64 | |||||
6-1 Month Momentum % | 0.8 | |||||
12-1 Month Momentum % | 8.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.04 | |||||
Quick Ratio | 0.3 | |||||
Cash Ratio | 0.09 | |||||
Days Inventory | 191.02 | |||||
Days Sales Outstanding | 28.43 | |||||
Days Payable | 123.24 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -3.49 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 26.62 | |||||
Operating Margin % | 5.24 | |||||
Net Margin % | 2.66 | |||||
FCF Margin % | -2.24 | |||||
ROE % | 6.78 | |||||
ROA % | 2.62 | |||||
ROIC % | 11.54 | |||||
ROC (Joel Greenblatt) % | 8.61 | |||||
ROCE % | 9.9 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 18.77 | |||||
PE Ratio without NRI | 18.77 | |||||
Shiller PE Ratio | 10.64 | |||||
PEG Ratio | 15.64 | |||||
PS Ratio | 0.5 | |||||
PB Ratio | 1.19 | |||||
Price-to-Tangible-Book | 1.5 | |||||
Price-to-Operating-Cash-Flow | 45.11 | |||||
EV-to-EBIT | 14.36 | |||||
EV-to-EBITDA | 7.53 | |||||
EV-to-Revenue | 0.69 | |||||
EV-to-FCF | -31.18 | |||||
Price-to-Projected-FCF | 1.06 | |||||
Price-to-Median-PS-Value | 0.94 | |||||
Price-to-Graham-Number | 1.12 | |||||
Earnings Yield (Greenblatt) % | 6.96 | |||||
FCF Yield % | -4.49 | |||||
Forward Rate of Return (Yacktman) % | 4.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mangalam Drugs & Organics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 3,533.653 | ||
EPS (TTM) (₹) | 5.94 | ||
Beta | 0.41 | ||
Volatility % | 39.09 | ||
14-Day RSI | 41.64 | ||
14-Day ATR (₹) | 5.676003 | ||
20-Day SMA (₹) | 117.26 | ||
12-1 Month Momentum % | 8.24 | ||
52-Week Range (₹) | 85.16 - 144.65 | ||
Shares Outstanding (Mil) | 15.83 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mangalam Drugs & Organics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mangalam Drugs & Organics Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Mangalam Drugs & Organics Ltd Frequently Asked Questions
What is Mangalam Drugs & Organics Ltd(BOM:532637)'s stock price today?
When is next earnings date of Mangalam Drugs & Organics Ltd(BOM:532637)?
Does Mangalam Drugs & Organics Ltd(BOM:532637) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |